Literature DB >> 1166991

Farewell to phenformin for treating diabetes mellitus.

R H Williams, J P Palmer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1975        PMID： 1166991     DOI： 10.7326/0003-4819-83-4-567

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  8 in total

Review 1.  Etiology and therapeutic approach to elevated lactate levels.

Authors:  Lars W Andersen; Julie Mackenhauer; Jonathan C Roberts; Katherine M Berg; Michael N Cocchi; Michael W Donnino
Journal:  Mayo Clin Proc       Date:  2013-10       Impact factor: 7.616

Review 2.  Lactic acidosis induced by metformin: incidence, management and prevention.

Authors:  Jean-Daniel Lalau
Journal:  Drug Saf       Date:  2010-09-01       Impact factor: 5.606

Review 3.  The management of diabetes mellitus in older individuals.

Authors:  J E Morley; H M Perry
Journal:  Drugs       Date:  1991-04       Impact factor: 9.546

4.  Metformin treatment in NIDDM patients with mild renal impairment.

Authors:  V Connolly; C M Kesson
Journal:  Postgrad Med J       Date:  1996-06       Impact factor: 2.401

Review 5.  Management of antidiabetic medications in overdose.

Authors:  H A Spiller
Journal:  Drug Saf       Date:  1998-11       Impact factor: 5.606

Review 6.  Lactic acidosis in biguanide-treated diabetics: a review of 330 cases.

Authors:  D Luft; R M Schmülling; M Eggstein
Journal:  Diabetologia       Date:  1978-02       Impact factor: 10.122

Review 7.  Prevention of complications in non-insulin-dependent diabetes mellitus (NIDDM).

Authors:  B H Wolffenbuttel; T W van Haeften
Journal:  Drugs       Date:  1995-08       Impact factor: 9.546

8.  Metformin associated lactic acidosis: a case series of 28 patients treated with sustained low-efficiency dialysis (SLED) and long-term follow-up.

Authors:  Andrea Angioi; Gianfranca Cabiddu; Maura Conti; Gianfranco Pili; Alice Atzeni; Valeria Matta; Riccardo Cao; Matteo Floris; Marco Songini; Maria Franca Mulas; Mitchell Rosner; Antonello Pani
Journal:  BMC Nephrol       Date:  2018-04-02       Impact factor: 2.388
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.